TECTONIC THERAPEUTIC, INC. Restructuring Charges
TECTONIC THERAPEUTIC, INC. (TECX) reported Restructuring Charges of $5.30 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2024-05-09
- TECTONIC THERAPEUTIC, INC. restructuring charges for the quarter ending 2024-03-31 was $5.30M.
- TECTONIC THERAPEUTIC, INC. restructuring charges for the quarter ending 2023-12-31 was $1.37M.
- TECTONIC THERAPEUTIC, INC. restructuring charges for fiscal 2023 was $5.06M.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2024-03-31 | $5.30M 10-Q · filed 2024-05-09 | $6.67M derived: sum of 2 quarters · filed 2024-05-09 | ||
| 2023-12-31 | $1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $5.06M 10-K · filed 2024-03-14 | ||
| 2023-09-30 | $3.69M 10-Q · filed 2023-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |